‘‘(4) promote personal influenza precautionary 
measures and knowledge, and the need for general 
vaccination, as appropriate; and 
‘‘(5) describe precautions at the State and local 
level that could be implemented during pandemic in-
fluenza, including quarantine and other measures. 
‘‘SEC. 2147. HEALTH PROFESSIONAL TRAINING. 
‘‘The Secretary, directly or through contract, and in 
consultation with professional health and medical soci-
eties, shall develop and disseminate pandemic influenza 
training curricula— 
‘‘(1) to educate and train health professionals, 
including physicians, nurses, public health practi-
tioners, virologists and epidemiologists, veterinar-
ians, mental health providers, allied health profes-
sionals, and paramedics and other first responders; 
‘‘(2) to educate and train volunteer, non-med-
ical personnel whose assistance may be required dur-
ing a pandemic influenza outbreak; and 
‘‘(3) that address prevention, including use of 
quarantine and other isolation precautions, pan-
demic influenza diagnosis, medical guidelines for use 
of antivirals and vaccines, and professional require-
ments and responsibilities, as appropriate.
‘‘SEC. 2148. RESEARCH AT THE NATIONAL INSTITUTES OF 
HEALTH. 
‘‘The Director of the National Institutes of Health 
(referred to in this section as the ‘Director of NIH’), in 
collaboration with the Director of the Centers for Disease 
Control and Prevention, and other relevant agencies, shall 
expand and intensify— 
‘‘(1) human and animal research, with respect 
to influenza, on— 
‘‘(A) vaccine development and manufac-
ture, 
including 
strategies 
to 
increase 
immunological response; 
‘‘(B) 
effectiveness 
of 
inducing 
heterosubtypic immunity; 
‘‘(C) antivirals, including minimal dose or 
course of treatment and timing to achieve pro-
phylactic or therapeutic effect; 
‘‘(D) side effects and drug safety of vac-
cines and antivirals in subpopulations; 
‘‘(E) alternative routes of delivery; 
‘‘(F) more efficient methods for testing 
and determining virus subtype; 
‘‘(G) protective measures; and 
‘‘(H) other areas determined appropriate 
by the Director of NIH; and
‘‘(2) historical research on prior pandemics to 
better understand pandemic epidemiology, trans-
mission, protective measures, high-risk groups, and 
other lessons that may be applicable to future 
pandemics. 
‘‘SEC. 2149. RESEARCH AT THE CENTERS FOR DISEASE CON-
TROL AND PREVENTION. 
‘‘The Director of the Centers for Disease Control and 
Prevention, in collaboration with other relevant agencies, 
shall expand and intensify research, with respect to influ-
enza, on— 
‘‘(1) communication strategies for the public 
during pandemic influenza, taking into consideration 
age, racial and ethnic background, health literacy, 
and risk status; 
‘‘(2) changing and influencing human behavior 
as it relates to vaccination; and 
‘‘(3) development and implementation of a pub-
lic, non-commercial and non-competitive broadcast 
system and person-to-person networks. 
‘‘SEC. 2150. INSTITUTE OF MEDICINE STUDY ON THE LEGAL, 
ETHICAL, AND SOCIAL IMPLICATIONS OF 
PANDEMIC INFLUENZA. 
‘‘(a) IN GENERAL.—The Secretary shall contract 
with the Institute of Medicine to—
‘‘(1) study the legal, ethical, and social implica-
tions of, with respect to pandemic influenza— 
‘‘(A) animal/human interchange; 
‘‘(B) global surveillance; 
‘‘(C) case contact investigations; 
‘‘(D) vaccination and medical treatment; 
‘‘(E) community hygiene; 
‘‘(F) travel and border controls; 
‘‘(G) decreased social mixing and increased 
social distance; 
‘‘(H) civil confinement; and 
‘‘(I) other topics as determined appropriate 
by the Secretary. 
‘‘(2) not later than 1 year after the date of en-
actment of the Attacking Viral Influenza Across Na-
tions Act of 2005, submit to the Secretary a report 
that describes recommendations based on the study 
conducted under paragraph (1). 
‘‘(b) IMPLEMENTATION
OF RECOMMENDATIONS.— 
Not later than 180 days after the submission of the report 
of under subsection (a)(2), the Secretary shall address the 
recommendations of the Institute of Medicine regarding 
the domestic and international allocation and distribution 
of pandemic influenza vaccine and antivirals.
‘‘SEC. 2151. NATIONAL PANDEMIC INFLUENZA ECONOMICS 
ADVISORY COMMITTEE. 
‘‘(a) IN GENERAL.—There is established the National 
Pandemic Influenza Economics Advisory Committee (re-
ferred to in this section as the ‘Committee’). 
‘‘(b) MEMBERSHIP.— 
‘‘(1) IN GENERAL.—The members of the Com-
mittee shall be appointed by the Comptroller General 
of the United States and shall include domestic and 
international experts on pandemic influenza, public 
health, veterinary science, commerce, economics, fi-
nance, and international diplomacy. 
‘‘(2) CHAIR.—The Comptroller General of the 
United States shall select a Chair from among the 
members of the Committee. 
‘‘(c) DUTIES.—The Committee shall study and make 
recommendations to Congress and the Secretary on the 
financial and economic impact of pandemic influenza and 
possible financial structures for domestic and inter-
national pandemic response, relating to— 
‘‘(1) the development, storage and distribution 
of vaccines; 
‘‘(2) the storage and distribution of antiviral 
and other medications and supplies; 
‘‘(3) increased surveillance activities;
‘‘(4) provision of preventive and medical care 
during pandemic; 
‘‘(5) reimbursement for health providers and 
other core public function employees; 
‘‘(6) reasonable compensation for farmers and 
other workers that bear direct or disproportionate 
loss of revenue; and 
‘‘(7) other issues determined appropriate by the 
Chair. 
‘‘(d) COMPENSATION.— 
‘‘(1) IN GENERAL.—Each member of the Com-
mittee who is not an officer or employee of the Fed-
eral Government shall be compensated at a rate 
equal to the daily equivalent of the annual rate of 
basic pay prescribed for level IV of the Executive 
Schedule under section 5315 of title 5, United 
States Code, for each day (including travel time) 
during which such member is engaged in the per-
formance of the duties of the Committee. All mem-
bers who are officers or employees of the United 
States shall serve without compensation in addition 
to that received for their services as officers or em-
ployees of the United States. 
‘‘(2) TRAVEL
EXPENSES.—A member of the 
Committee shall be allowed travel expenses, includ-